Tin Fluorides: Clinical Trials

13 trials of Tin Fluorides, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 1 recruiting. 13 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 313Completed 12, Recruiting 1
Phase 22Completed 2

Follow Tin Fluorides: new trials by email Literature Review of Tin Fluorides trials Research Report on Tin Fluorides

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice
Stannous fluoride and Potassium nitrate Dentifrice, Stannous fluoride Dentifrice, Potassium nitrate Dentifrice - Dentin Hypersensitivity
Phase 3CompletedHALEON6882025-09-162026-08-25
Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Experimental drug, Control Rx - Metastatic Microsatellite-stable Colorectal Cancer
Phase 3RecruitingSun Yat-sen University1762023-03-012023-03-14
A Clinical Study Conducted in the Bangkok, Thailand Area, to Investigate the Clinical Efficacy of a New Toothpaste
0.454% stannous fluoride, 0.76% sodium monofluorophosphate - Oral Malodor
Phase 3CompletedColgate Palmolive802017-12-212025-10-31
Efficacy of Toothpaste Containing 0.454% Stannous Fluoride as Compared to a Regular Fluoride Toothpaste Containing 0.76% Sodium Monofluorophosphate in Controlling Supragingival Calculus Formation Over a 12-week Period.
0.454% stannous fluoride, 0.76% sodium monofluorophosphate - Calculus, Dental
Phase 2 / Phase 3CompletedColgate Palmolive1002017-05-172025-12-11
Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
stannous fluoride, sodium monofluorophosphate - Dentin Sensitivity
Phase 3CompletedGlaxoSmithKline2422016-03-012017-05-25
A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride
Stannous fluoride, Sodium monofluorophosphate - Gingivitis
Phase 3CompletedGlaxoSmithKline982013-05-282020-01-31
Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity
Stannous fluoride, Sodium monofluorophosphate - Dentine Hypersensitivity
Phase 3CompletedGlaxoSmithKline1192013-02-012015-01-26
Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity
Stannous Fluoride, Sodium Monofluorophosphate - Dentine Hypersensitivity
Phase 3CompletedGlaxoSmithKline1132012-04-012014-06-03
The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity
Stannous Fluoride, Sodium Monofluorophosphate - Dentine Hypersensitivity
Phase 3CompletedGlaxoSmithKline1202012-03-012018-03-06
The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity
Stannous Fluoride, Sodium Monofluorophosphate - Dentine Hypersensitivity
Phase 3CompletedGlaxoSmithKline1202012-03-012014-03-10
Donor Simvastatin Treatment in Organ Transplantation
Simvastatin 80mg, Control Rx - Heart Failure, Respiratory Failure
Phase 2 / Phase 3CompletedHelsinki University Central Hospital842010-06-012017-09-19
Investigate Oral Bacteria in Adult Population
Fluoride, Fluoride, Triclosan, Stannous Fluoride - Oral Bacteria
Phase 3CompletedColgate Palmolive242008-05-012011-03-23
Non-Pharmacologic Interventions to Relief Pain in Healthy Newborns Submitted to Vaccination to Hepatitis B
Water 2mL PO 2 minutes prior to intra-muscular injection, skin-to-skin contact, Glucose 25% 2 mL PO 2 minutes prior to injection - Pain, Analgesia
Phase 3CompletedFederal University of São Paulo6402006-03-012008-07-14

Conditions studied

Dentin Sensitivity (6)  ·  Agnosia (1)  ·  Colorectal Neoplasms (1)  ·  Dental Calculus (1)  ·  Gingivitis (1)  ·  Heart Failure (1)  ·  Liver Failure (1)  ·  Pain (1)  ·  Rejection, Psychology (1)  ·  Renal Insufficiency (1)  ·  Reperfusion Injury (1)  ·  Respiratory Insufficiency (1)

Sponsors

GlaxoSmithKline (6)  ·  Colgate Palmolive (3)  ·  Federal University of São Paulo (1)  ·  HALEON (1)  ·  Helsinki University Central Hospital (1)  ·  Sun Yat-sen University (1)

Countries

United States (7)  ·  Thailand (2)  ·  China (1)  ·  Finland (1)  ·  Ireland (1)

Top investigators

Aurimery G Chermont (1)  ·  Daniel Fine, DDS (1)  ·  Dutmanee Seriwatanachai (1)  ·  Jeffery L Milleman (1)  ·  John T Gallob (1)  ·  Karl B Lemstrom, MD, PhD (1)  ·  Pejmon Amini (1)  ·  Ruihua Xu, MD (1)  ·  Ruth Guinsburg (1)  ·  Terdphong Triratana, DDS (1)

Results publications

PMID 27093773, PMID 19948613, PMID 26437498, PMID 31164116, PMID 31352795, PMID 32216778